OIA
BPMC

Optimum Investment Advisors’s Blueprint Medicines BPMC Stock Holding History

Optimum Investment Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$8K – 940
2019
Q1 		$8K Hold
100
– – ﹤0.01% 838
2018
Q4 		$5K Hold
100
– – ﹤0.01% 842
2018
Q3 		$8K Buy
+100
New +$6.95K ﹤0.01% 872

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Optimum Investment Advisors's BPMC Position: Q2 2019 in Review

Optimum Investment Advisors sold out of Blueprint Medicines (BPMC) in Q2 2019, closing a stake of 100 shares — an estimated $8K sold.

Optimum Investment Advisors first reported a position in BPMC in Q3 2018 and held it in 3 quarters. The position peaked at $8K in Q1 2019. 220 funds tracked by Wall St. Rank hold BPMC as of Q2 2019.

  • Optimum Investment Advisors reported no remaining Blueprint Medicines position as of Q2 2019 after selling out during the quarter.
  • Optimum Investment Advisors sold 100 Blueprint Medicines shares in Q2 2019, an estimated $8K.
  • Optimum Investment Advisors first reported a position in Blueprint Medicines in Q3 2018 and held it in 3 quarters.
  • Optimum Investment Advisors's Blueprint Medicines position peaked at $8K in Q1 2019.
  • 220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2019.

Based on Optimum Investment Advisors's 13F filing for Q2 2019, filed 29 Jul 2019.